FDA Approved: ALCLOMETASONE DIPROPIONATE — Supplemental Application (Glenmark Pharmaceuticals Inc., USA)

View source ↗

Summary

FDA approved a supplemental application for alclometasone dipropionate by Glenmark Pharmaceuticals, approving changes to the product labeling.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atopic Dermatitis
• Dermatitis

Drugs mentioned

• ALCLOMETASONE DIPROPIONATE (ALCLOMETASONE DIPROPIONATE)

Snippet

SUPPL AP for ALCLOMETASONE DIPROPIONATE (ALCLOMETASONE DIPROPIONATE)